Zealand University Hospital

At Zealand University Hospital, clinical trials in cardiovascular disease and metabolic disorders focus on common and high-risk conditions such as atrial fibrillation, myocardial infarction, heart failure, and atherosclerotic cardiovascular disease. These studies are designed to test new treatment strategies, improve prevention, and better understand how to reduce serious events like stroke and heart-related complications.

• Trials in atrial fibrillation and stroke prevention are evaluating safer and more effective ways to lower clotting risk.
• Research in heart failure and acute coronary syndromes is assessing therapies aimed at improving outcomes after major cardiac events.
• Studies in cardiometabolic disease are exploring new options for prevention in people at elevated cardiovascular risk.

This work combines treatment evaluation with prevention-focused research, reflecting a strong interest in both acute care and long-term disease management.

The site is active in respiratory medicine and infectious disease research, with trials addressing chronic obstructive pulmonary disease, COVID-19, and other serious respiratory infections. The overall goal is to improve symptom control, reduce flare-ups, and support recovery in hospitalized and outpatient settings.

• Studies in COPD are examining ways to reduce exacerbations and improve day-to-day breathing-related outcomes.
• Research in COVID-19 and acute respiratory infections is testing treatments intended to improve clinical recovery in hospitalized adults.
• Additional work in pulmonary sarcoidosis is exploring new therapies to control inflammation and lessen steroid use.

This portfolio highlights a mix of treatment testing and supportive-care research for patients with complex lung disease.

Clinical research in cancer and blood disorders covers a broad range of malignancies, including breast cancer, colorectal cancer, endometrial cancer, lung cancer, melanoma, lymphoma, chronic lymphocytic leukemia, and multiple myeloma. These trials are largely aimed at improving survival, preventing recurrence, and finding better ways to combine or sequence treatments.

• Cancer studies are testing new approaches for both solid tumors and hematologic malignancies.
• Several trials focus on immunotherapy and other targeted strategies to improve treatment effectiveness.
• Hematology research includes studies for lymphoma, leukemia, and myeloma with an emphasis on better disease control.

The Department of Surgery also contributes to studies around cancer-related procedures and supportive care, showing a strong link between operative care and oncology research.

Trials in digestive system diseases and liver disease are examining conditions such as non-alcoholic steatohepatitis, liver cirrhosis, pancreatic cancer, and colorectal cancer. This research aims to improve disease management, reduce complications, and evaluate new therapies for both chronic and advanced gastrointestinal conditions.

• Studies in NASH and cirrhosis are focused on liver inflammation, fibrosis, and related complications.
• Research in pancreatic and colorectal cancer includes efforts to improve tumor control and support perioperative care.
• Additional work addresses acute digestive problems such as esophageal food impaction.

These studies reflect a broad interest in both chronic liver disease and surgical gastrointestinal care, with an emphasis on practical clinical benefit.

Research in immune-mediated and inflammatory diseases includes trials for hidradenitis suppurativa, atopic dermatitis, systemic lupus erythematosus, and breast cancer-related lymphedema. The purpose of these studies is to assess new therapies that may reduce inflammation, improve quality of life, and relieve persistent symptoms.

• Trials in hidradenitis suppurativa and atopic dermatitis are evaluating better symptom control for chronic skin disease.
• Work in systemic lupus erythematosus is focused on improving immune disease activity and treatment response.
• Studies in lymphedema are looking at ways to reduce swelling and improve function after cancer treatment.

This area shows strong activity in conditions where inflammation, immune regulation, and long-term symptom burden are central concerns.

The site also supports trials in neurologic and perioperative care settings, including acute ischemic stroke, viral meningitis, postoperative pain, and anxiety around surgery. These studies are intended to improve recovery, comfort, and clinical outcomes before, during, and after treatment.

• Stroke research is testing new ways to support recovery and improve outcomes in urgent care.
• Studies in meningitis and other acute neurologic conditions are evaluating whether existing treatments can improve symptom burden.
• Surgical research includes approaches to reduce pain and preoperative anxiety for patients undergoing major procedures.

This mix of studies links emergency medicine, surgery, and symptom relief, with a clear focus on patient-centered care.